The potential epidemiological impact of a genital herpes vaccine for women
Open Access
- 1 February 2004
- journal article
- research article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 80 (1) , 24-29
- https://doi.org/10.1136/sti.2002.003848
Abstract
Objectives: To evaluate point prevalence vaginal yeast colonisation and symptomatic vaginitis in middle adolescents and to identify relation of these yeast conditions with reproductive hormones, sexual activity, sexual behaviours, and associated local immunity. Methods: Middle adolescent females (n = 153) were evaluated for sexually transmitted infections (STIs), asymptomatic yeast colonisation, and symptomatic vulvovaginal candidiasis (VVC) by standard criteria. Also evaluated were local parameters, including vaginal associated cytokines, chemokines, and antibodies, vaginal epithelial cell antifungal activity, and Candida specific peripheral blood lymphocyte responses. Correlations between yeast colonisation/vaginitis and local immunomodulators, reproductive hormones, douching, sexual activity, condom use, and STIs were identified. Results: Rates of point prevalence asymptomatic yeast colonisation (22%) were similar to adults and similarly dominated by Candida albicans, but with uncharacteristically high vaginal yeast burden. In contrast with the high rate of STIs (18%), incidence of symptomatic VVC was low (Candida specific systemic immune sensitisation, a Th2 type vaginal cytokine profile, total and Candida specific vaginal antibodies dominated by IgA, and moderate vaginal epithelial cell anti-Candida activity. Endogenous reproductive hormones were in low concentration. Sexual activity positively correlated with vaginal yeast colonisation, whereas vaginal cytokines (Th1, Th2, proinflammatory), chemokines, antibodies, contraception, douching, or condom use did not. Conclusion: Asymptomatic vaginal yeast colonisation in adolescents is distinct in some ways with adults, and positively correlates with sexual activity, but not with local immunomodulators or sexual behaviours. Despite several factors predictive for VVC, symptomatic VVC was low compared to STIs.Keywords
This publication has 16 references indexed in Scilit:
- Glycoprotein-D–Adjuvant Vaccine to Prevent Genital HerpesNew England Journal of Medicine, 2002
- Measuring the risk of HIV transmissionAIDS, 2001
- Mathematical Models of the Transmission and Control of Sexually Transmitted DiseasesSexually Transmitted Diseases, 2000
- A Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2New England Journal of Medicine, 1999
- Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2Sexually Transmitted Infections, 1999
- Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.Journal of Clinical Investigation, 1997
- Estimability and Interpretation of Vaccine Efficacy Using Frailty Mixing ModelsAmerican Journal of Epidemiology, 1996
- Sex acts, sex partners, and sex budgets: implications for risk factor analysis and estimation of HIV transmission probabilities.1993
- Risk Factors for the Sexual Transmission of Genital HerpesAnnals of Internal Medicine, 1992
- Frequency of Acquisition of First-episode Genital Infection with Herpes Simplex Virus from Symptomatic and Asymptomatic Source ContactsSexually Transmitted Diseases, 1985